Fit-for-Purpose Biomarker Assay Validation - From Research Tool to Diagnostic Test
Jeff Cummings, Cancer Research UK, speaking at Diagnostics & Biomarkers 2015.
Tissue and cfDNA Rare Alleles How Low Can We Go
Seth Crosby, Washington University School of Medicine, speaking at Diagnostics & Biomarkers 2015
New Metabolomics Biomarker for Heart Failure
Philipp Schatz, Metanomics Health GmbH, speaking at Diagnostics & Biomarkers 2015.
Exploring Protein-protein Interactions Using Scaffolded and Assembled Peptides as Synthetic Binding Site Mimics
Jutta Eichler, University of Erlangen-Nuremberg, speaking at Discovery Chemistry Congress 2015.
Continuous Flow Synthesis: Laboratory Approach & Protocol for Scale-up
Amol Kulkarni, National Chemical Laboratory, speaking at Flow Chemistry India.
Choosing & Using Fragments in the Generation of Selective Kinase Inhibitors
Lee Walmsley, Vernalis Ltd, speaking at Discovery Chemistry Congress 2015.
Bioorthogonal Palladium-Labile Prodrugs for Site-Specific Anticancer Therapy
Asier Unciti-Broceta, University of Edinburgh, speaking at Discovery Chemistry Congress 2015.
Transporter Knockout Cell Lines in Preclincal Toxicology Assays and Services
Join this webinar to learn how advanced ADME and toxicology services can help in the efficient development of drugs.
Creating a Clinical Diagnostic Test from Discovery Through Launch with Mass Spectrometry
Daniel Chelsky, Caprion Proteomics Inc, speaking at Diagnostics & Biomarkers 2015.
LC-High Resolution-MS in Clinical Labs: A Step Forward for TDM and Metabotyping
Bertrand Rochat, Centre Hospitalier Universitaire Vaudois, speaking at Clinical Applications of Mass Spectrometry.
|<<|| 1 2 3 4 5 6 7 || >>|
|Showing Results 1 - 10 of 1215|